Latest Shareholder Equity News

Amplitude Energy has successfully closed a $150 million equity raising, including a $19 million retail entitlement offer, positioning the company to expand its East Coast Supply Project and potentially restart the Patricia Baleen project.

Cedar Woods Properties has activated its Dividend Reinvestment and Bonus Share Plans for the final 2025 dividend, offering shares at a 2.5% discount and backed by full underwriting from major brokers.

Trigg Minerals is advancing its strategy to list on the U.S. NASDAQ, weighing options including a dual listing and potential SPAC mergers, while planning a name change to reflect its evolving focus.

Rumble Resources has successfully completed a non-renounceable entitlement offer, raising nearly A$2 million despite a modest 39% take-up on entitlements and a significant scale-back on shortfall applications.

XRF Scientific Limited has confirmed its fully franked ordinary dividend for the 2025 financial year and updated details of its Dividend Reinvestment Plan price, offering shareholders a clear view on income and reinvestment options.

Laserbond Limited has updated its dividend announcement to specify the issue date for shares under its Dividend Reinvestment Plan, reinforcing its commitment to shareholder returns for the first half of FY2025.

WiseTech Global has updated its dividend announcement, confirming a fully franked ordinary dividend for the half-year ending June 2025 and setting the Dividend Reinvestment Plan price at AUD 96.75.

Klevo Rewards Limited has initiated a non-renounceable entitlement offer to raise up to $4.1 million by issuing new shares at $0.009 each, inviting existing shareholders to participate by 1 October 2025.

Kogan.com Ltd has announced a fully franked ordinary dividend of 7 cents per share for the six months ending June 2025, alongside details of its Dividend Reinvestment Plan pricing.

Neurizon Therapeutics has locked in a significant R&D tax incentive advance covering overseas and domestic development costs for its lead ALS drug candidate NUZ-001, accelerating its clinical progress with a $5.6 million rebate expected in 2025.

Vulcan Steel has successfully closed its entitlement offer, raising A$87.1 million to fund the strategic acquisition of Roofing Industries Limited. The retail shortfall bookbuild sold shares at a premium, rewarding shareholders who did not fully participate.

IPH Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.195 per share and setting the Dividend Reinvestment Plan price at AUD 4.21 per share.